TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $65,594,000 | +167.5% | 871,686 | -4.6% | 0.01% | +233.3% |
| Q1 2022 | $24,523,000 | -43.0% | 913,367 | +1.3% | 0.00% | -40.0% |
| Q4 2021 | $42,995,000 | -22.1% | 901,383 | +8.5% | 0.01% | -28.6% |
| Q3 2021 | $55,163,000 | -9.9% | 830,400 | +5.8% | 0.01% | -12.5% |
| Q2 2021 | $61,250,000 | -4.5% | 785,056 | +15.8% | 0.01% | -20.0% |
| Q1 2021 | $64,126,000 | -16.1% | 677,940 | +8.1% | 0.01% | -23.1% |
| Q4 2020 | $76,422,000 | +62.7% | 627,182 | +16.6% | 0.01% | +44.4% |
| Q3 2020 | $46,975,000 | +96.1% | 537,720 | +45.0% | 0.01% | +80.0% |
| Q2 2020 | $23,955,000 | +71.7% | 370,883 | +18.7% | 0.01% | +25.0% |
| Q1 2020 | $13,950,000 | -58.7% | 312,368 | -42.4% | 0.00% | 0.0% |
| Q4 2019 | $33,792,000 | +511.4% | 542,510 | +269.0% | 0.00% | +300.0% |
| Q3 2019 | $5,527,000 | +15.6% | 147,019 | +25.2% | 0.00% | 0.0% |
| Q2 2019 | $4,780,000 | – | 117,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |